
Aptiv stock trades near US$47.95 after a steep multi year decline, and the valuation checks now offer a mixed picture rather than a clear bargain or clear overpricing. Long term returns have been weak, while several of the traditional market multiples suggest the shares may be pricing in cautious expectations already. Aptiv shareholders have seen the stock fall about 61.3% over 5 years, which means anyone looking at the shares today is doing so after a prolonged reset in market...



